Last reviewed · How we verify
Belotero Balance
Belotero Balance is a hyaluronic acid-based dermal filler that restores volume and smooths wrinkles by integrating into the dermis.
Belotero Balance is a hyaluronic acid-based dermal filler that restores volume and smooths wrinkles by integrating into the dermis. Used for Correction of moderate to severe facial wrinkles and folds, Lip augmentation and enhancement.
At a glance
| Generic name | Belotero Balance |
|---|---|
| Sponsor | The Maas Clinic |
| Drug class | Dermal filler |
| Target | Hyaluronic acid receptor (CD44) |
| Modality | Small molecule |
| Therapeutic area | Dermatology/Aesthetics |
| Phase | FDA-approved |
Mechanism of action
Belotero Balance uses a patented technology to create a cohesive polydensified matrix of hyaluronic acid that integrates seamlessly into the skin's dermal layer. This provides natural-looking volume restoration and smoothing of facial lines and wrinkles. The formulation is designed to be flexible and adapt to facial movements while maintaining aesthetic results.
Approved indications
- Correction of moderate to severe facial wrinkles and folds
- Lip augmentation and enhancement
Common side effects
- Injection site erythema
- Injection site swelling
- Injection site bruising
- Injection site pain
- Temporary nodules
Key clinical trials
- USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
- Clinical Investigation on Lips Treated With HA-filler (NA)
- Using Different Biomaterials to Preserve Bone After Tooth Extraction (NA)
- Hyaluronic Acid and Albumin-PRF in Non-Surgical Periodontal Therapy (NA)
- Early vs Delayed Intravesical Blad-Care During BCG Therapy (NA)
- A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF) (NA)
- Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? (NA)
- A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Belotero Balance CI brief — competitive landscape report
- Belotero Balance updates RSS · CI watch RSS
- The Maas Clinic portfolio CI